Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands |
6 Months Ended |
Aug. 31, 2023 |
Aug. 31, 2022 |
| Cash Flows from Operating Activities |
|
|
| Net loss |
$ (11,751)
|
$ (25,711)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Depreciation and amortization (Notes 6 and 7) |
268
|
277
|
| Stock-based compensation expense (Note 15) |
743
|
9,095
|
| Accretion and accrued interest expenses (Note 10) |
36
|
79
|
| Changes in operating assets and liabilities: |
|
|
| Sales tax and tax credits receivable (Note 3) |
(114)
|
(143)
|
| Inventories (Note 4) |
(175)
|
(330)
|
| Prepaid expenses (Note 5) |
510
|
124
|
| Accounts payable and accrued liabilities (Note 9) |
(522)
|
(2,799)
|
| Customer deposits |
(12)
|
0
|
| Net cash used in operating activities |
(11,017)
|
(19,408)
|
| Cash Flows from Investing Activities |
|
|
| Deposits on equipment (Note 5) |
(5,065)
|
(1,271)
|
| Additions to property, plant and equipment (Note 6) |
0
|
(58)
|
| Additions to intangible assets (Note 7) |
(225)
|
(141)
|
| Net cash used in investing activities |
(5,290)
|
(1,470)
|
| Cash Flows from Financing Activities |
|
|
| Repayment of long-term debt (Note 10) |
(32)
|
0
|
| Net cash (used) provided by financing activities |
(32)
|
0
|
| Effect of exchange rate changes |
113
|
(183)
|
| Net decrease in cash |
(16,226)
|
(21,061)
|
| Cash, cash equivalents and restricted cash, beginning of period |
30,591
|
44,061
|
| Cash, cash equivalents and restricted cash, end of period |
14,365
|
23,000
|
| Supplemental Disclosure of Cash Flow Information: |
|
|
| Income tax paid |
0
|
0
|
| Interest paid |
43
|
0
|
| Interest received |
$ 213
|
$ 23
|